ifosfamide has been researched along with Hepatoblastoma in 11 studies
Hepatoblastoma: A malignant neoplasm occurring in young children, primarily in the liver, composed of tissue resembling embryonal or fetal hepatic epithelium, or mixed epithelial and mesenchymal tissues. (Stedman, 25th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The Cooperative German Paediatric Liver Tumour Study HB89 was conceived to evaluate the efficiency and toxicity of ifosfamide, cisplatin and doxorubicin (IPA) in children with resectable and non-resectable hepatoblastoma (HB) and to determine late sequelae including tubular nephropathy of tumour treatment." | 9.08 | Efficiency and toxicity of ifosfamide, cisplatin and doxorubicin in the treatment of childhood hepatoblastoma. Study Committee of the Cooperative Paediatric Liver Tumour Study HB89 of the German Society for Paediatric Oncology and Haematology. ( Bode, U; Bürger, D; Byrd, DJ; Erttmann, R; Harms, D; Hecker, H; Mildenberger, H; von Schweinitz, D; Weinel, P, 1997) |
| "Hepatoblastoma is the most common primary malignant liver tumor affecting infants and young children." | 5.30 | Comparative activity of cisplatin, ifosfamide, doxorubicin, carboplatin, and etoposide in heterotransplanted hepatoblastoma. ( Fuchs, J; Haindl, J; Leuschner, I; von Schweinitz, D; Wenderoth, M, 1998) |
| "The Cooperative German Paediatric Liver Tumour Study HB89 was conceived to evaluate the efficiency and toxicity of ifosfamide, cisplatin and doxorubicin (IPA) in children with resectable and non-resectable hepatoblastoma (HB) and to determine late sequelae including tubular nephropathy of tumour treatment." | 5.08 | Efficiency and toxicity of ifosfamide, cisplatin and doxorubicin in the treatment of childhood hepatoblastoma. Study Committee of the Cooperative Paediatric Liver Tumour Study HB89 of the German Society for Paediatric Oncology and Haematology. ( Bode, U; Bürger, D; Byrd, DJ; Erttmann, R; Harms, D; Hecker, H; Mildenberger, H; von Schweinitz, D; Weinel, P, 1997) |
| "The purpose of the German HB99 trial (1999-2008) for hepatoblastoma (HB), was primarily to analyse the effect of high dose (HD) chemotherapy with carboplatin/etoposide (CE) in high risk (HR) patients with extended tumors, vessel involvement, extrahepatic tumor or distant metastases." | 3.91 | High Dose Chemotherapy with Autologous Stem Cell Transplantation in Hepatoblastoma does not Improve Outcome. Results of the GPOH Study HB99. ( Häberle, B; Maxwell, R; Schmid, I; Schweinitz, DV, 2019) |
| "To evaluate the efficacy and safety of the ICE regimen (iphosphamide + carboplatin + etoposide) used in treating children with hepatoblastoma in the Shanghai Children's Medical Center." | 3.75 | [Clinical observation on the treatment outcome of 14 children with hepatoblastoma in a single medical center]. ( Chen, J; Dong, L; Gu, LJ; Jiang, H; Pan, C; Tang, JY; Xue, HL; Ye, QD; Zhou, M, 2009) |
| " Surgical biopsy performed after the first IPA (ifosfamide, cisplatin, doxorubicin) course showed hepatoblastoma with macrotrabecular variant." | 3.73 | Unresectable multifocal hepatoblastoma with cardiac extension: excellent response with HB-94 chemotherapy protocol. ( Anik, Y; Corapçioğlu, F; Sarper, N; Tugay, M; Ural, D; Yildiz, K, 2006) |
| "Hepatoblastoma is the most common primary malignant liver tumor affecting infants and young children." | 1.30 | Comparative activity of cisplatin, ifosfamide, doxorubicin, carboplatin, and etoposide in heterotransplanted hepatoblastoma. ( Fuchs, J; Haindl, J; Leuschner, I; von Schweinitz, D; Wenderoth, M, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, H | 1 |
| Zhang, W | 1 |
| Zhang, Y | 1 |
| Gao, Y | 1 |
| Zhi, T | 1 |
| Li, F | 1 |
| Li, J | 1 |
| Gu, H | 1 |
| Liao, R | 1 |
| Wu, R | 1 |
| Huang, D | 1 |
| Häberle, B | 1 |
| Maxwell, R | 1 |
| Schweinitz, DV | 1 |
| Schmid, I | 1 |
| Natarajan, E | 1 |
| Auerbach, C | 1 |
| Cheron, R | 1 |
| Pashankar, F | 1 |
| Hiyama, E | 2 |
| Hishiki, T | 2 |
| Watanabe, K | 2 |
| Ida, K | 2 |
| Yano, M | 2 |
| Oue, T | 2 |
| Iehara, T | 1 |
| Hoshino, K | 1 |
| Koh, K | 1 |
| Tanaka, Y | 1 |
| Kurihara, S | 1 |
| Ueda, Y | 1 |
| Onitake, Y | 1 |
| Gutweiler, JR | 1 |
| Yu, DC | 1 |
| Kim, HB | 1 |
| Kozakewich, HP | 1 |
| Marcus, KJ | 1 |
| Shamberger, RC | 1 |
| Weldon, CB | 1 |
| Pan, C | 1 |
| Tang, JY | 1 |
| Chen, J | 1 |
| Xue, HL | 1 |
| Dong, L | 1 |
| Zhou, M | 1 |
| Jiang, H | 1 |
| Ye, QD | 1 |
| Gu, LJ | 1 |
| Matsunaga, T | 1 |
| Sasaki, F | 1 |
| Horie, H | 1 |
| Kondo, S | 1 |
| Tajiri, T | 1 |
| Kamimatsuse, A | 1 |
| Ohnuma, N | 1 |
| Fuchs, J | 2 |
| Rydzynski, J | 1 |
| Hecker, H | 2 |
| Mildenberger, H | 2 |
| Bürger, D | 2 |
| Harms, D | 2 |
| V Schweinitz, D | 1 |
| Sarper, N | 1 |
| Corapçioğlu, F | 1 |
| Anik, Y | 1 |
| Ural, D | 1 |
| Yildiz, K | 1 |
| Tugay, M | 1 |
| von Schweinitz, D | 2 |
| Byrd, DJ | 1 |
| Weinel, P | 1 |
| Bode, U | 1 |
| Erttmann, R | 1 |
| Wenderoth, M | 1 |
| Haindl, J | 1 |
| Leuschner, I | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Combined Modality Therapy in Hepatoblastoma: South Egypt Cancer Institute Experience[NCT02557750] | 35 participants (Anticipated) | Observational | 2016-01-31 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for ifosfamide and Hepatoblastoma
| Article | Year |
|---|---|
Efficiency and toxicity of ifosfamide, cisplatin and doxorubicin in the treatment of childhood hepatoblastoma. Study Committee of the Cooperative Paediatric Liver Tumour Study HB89 of the German Society for Paediatric Oncology and Haematology.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Child; Child, Preschool; Cis | 1997 |
10 other studies available for ifosfamide and Hepatoblastoma
| Article | Year |
|---|---|
Individualized chemotherapy and efficacy analysis of hepatoblastoma in children.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Cisplatin; Cyclophosphamide; Eto | 2024 |
High Dose Chemotherapy with Autologous Stem Cell Transplantation in Hepatoblastoma does not Improve Outcome. Results of the GPOH Study HB99.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; D | 2019 |
Sustained Remission After Maintenance Irinotecan in Patient With Multiply Relapsed Hepatoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Chemotherapy, Adjuvant; D | 2020 |
Resectability and tumor response after preoperative chemotherapy in hepatoblastoma treated by the Japanese Study Group for Pediatric Liver Tumor (JPLT)-2 protocol.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Ci | 2016 |
Hepatoblastoma presenting with focal nodular hyperplasia after treatment of neuroblastoma.
Topics: Adrenal Gland Neoplasms; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplas | 2008 |
[Clinical observation on the treatment outcome of 14 children with hepatoblastoma in a single medical center].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Etoposide; Fem | 2009 |
Outcome of hepatoblastomas treated using the Japanese Study Group for Pediatric Liver Tumor (JPLT) protocol-2: report from the JPLT.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Com | 2011 |
The influence of preoperative chemotherapy and surgical technique in the treatment of hepatoblastoma--a report from the German Cooperative Liver Tumour Studies HB 89 and HB 94.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali | 2002 |
Unresectable multifocal hepatoblastoma with cardiac extension: excellent response with HB-94 chemotherapy protocol.
Topics: alpha-Fetoproteins; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Calcinosi | 2006 |
Comparative activity of cisplatin, ifosfamide, doxorubicin, carboplatin, and etoposide in heterotransplanted hepatoblastoma.
Topics: alpha-Fetoproteins; Animals; Antineoplastic Agents; Carboplatin; Cell Division; Child, Preschool; Ci | 1998 |